Protein p56 from the Bacillus subtilis phage phi 29 inhibits DNA-binding ability of uracil-DNA glycosylase by Serrano-Heras, Gemma et al.
Published online 13 August 2007 Nucleic Acids Research, 2007, Vol. 35, No. 16 5393–5401
doi:10.1093/nar/gkm584
Protein p56 from the Bacillus subtilis phage r29
inhibits DNA-binding ability of uracil-DNA
glycosylase
Gemma Serrano-Heras1, Jose´ A. Ruiz-Maso´2, Gloria del Solar2, Manuel Espinosa2,
Alicia Bravo2 and Margarita Salas1,*
1Instituto de Biologı´a Molecular ‘Eladio Vin˜uela’ (CSIC), Centro de Biologı´a Molecular ‘Severo Ochoa’ (CSIC-UAM),
Universidad Auto´noma, Cantoblanco, 28049 Madrid and 2Centro de Investigaciones Biolo´gicas (CSIC), Ramiro
de Maeztu 9, 28040 Madrid, Spain
Received April 27, 2007; Revised July 16, 2007; Accepted July 17, 2007
ABSTRACT
Protein p56 (56 amino acids) from the Bacillus
subtilis phage r29 inactivates the host uracil-DNA
glycosylase (UDG), an enzyme involved in the base
excision repair pathway. At present, p56 is the only
known example of a UDG inhibitor encoded by a
non-uracil containing viral DNA. Using analytical
ultracentrifugation methods, we found that protein
p56 formed dimers at physiological concentrations.
In addition, circular dichroism spectroscopic ana-
lyses revealed that protein p56 had a high content of
b-strands (around 40%). To understand the mecha-
nism underlying UDG inhibition by p56, we carried
out in vitro experiments using the Escherichia coli
UDG enzyme. The highly acidic protein p56 was able
to compete with DNA for binding to UDG. Moreover,
the interaction between p56 and UDG blocked DNA
binding by UDG. We also demonstrated that Ugi,
a protein that interacts with the DNA-binding
domain of UDG, was able to replace protein p56
previously bound to the UDG enzyme. These results
suggest that protein p56 could be a novel naturally
occurring DNA mimicry.
INTRODUCTION
Uracil in DNA may arise from the occasional use of
dUTP during DNA replication and from spontaneous
deamination of cytosine, which is one of the major pro-
mutagenic events in DNA. To maintain the integrity of the
genetic information, most prokaryotic and eukaryotic
cells encode uracil-DNA glycosylases (UDGs). These
enzymes recognize and remove uracil residues from
DNA by the base excision repair (BER) pathway.
In human cells, ﬁve distinct UDG activities have been
identiﬁed namely UNG1, UNG2, TDG, MBD4 and
SMUG (1). UNG2 is known to enter the nucleus while
the isoform UNG1 enters the mitochondria (2). Moreover,
UNG2 plays an important role in immunoglobulin
gene diversiﬁcation (3) and is incorporated into virions of
the human immunodeﬁciency virus type-1 (4,5). Some
DNA viruses, such as herpesviruses and poxviruses,
also encode a UDG activity. In these instances, the UDG
activity appears to have an important role in virus
replication (6).
The ﬁrst UDG activity reported was puriﬁed from
Escherichia coli cells. Since then, enzymes highly homolo-
gous to the archetypal E. coli UDG have been puriﬁed
from numerous organisms, including herpes simplex virus
type-1 and human cells (UNG1 and UNG2 enzymes).
These UDGs (Family-1) are able to eliminate uracil bases
eﬃciently from both single-stranded (ss) and double-
stranded (ds) DNAs regardless of the partner base, U:A
or U:G (7). However, in some cases, a preference for the
ssDNA substrates has been reported (8,9). Furthermore,
a mismatch-speciﬁc uracil-DNA glycosylase (MUG) was
puriﬁed from E. coli cells (10). This enzyme, which is
related to human thymine-DNA glycosylase (TDG) (11),
is exclusively active against U:G mismatches. Both MUG
and TDG are members of the Family-2 UDGs (7).
During the last years, UDGs are emerging as attractive
therapeutic targets due to their role in a wide range of
biological processes. Hence, the discovery of small
molecules able to inhibit the activity of particular UDGs
has a great interest. In addition, the knowledge generated
by studying new UDG inhibitors should provide further
insights into the process of substrate recognition and
catalysis by UDGs. The ﬁrst natural UDG inhibitor
reported was Ugi, a highly acidic protein (84 amino acids)
encoded by the Bacillus subtilis phage PBS2, whose
DNA genome is unusual in that it contains uracil
instead of thymine (12). Ugi inactivates Family-1
UDGs from B. subtilis, E. coli, Micrococcus luteus,
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Saccharomyces cerevisae, rat liver, herpes simplex virus,
and humans (13–15), but not other DNA glycosylases
(14). The X-ray crystal structures of Ugi in complex with
diﬀerent UDGs revealed that Ugi mimics electronegative
and structural features of duplex DNA (16–18). Some
synthetic inhibitors of UDGs have also been described.
Among them, uracil derivatives and oligonucleotide-based
substrates were shown to inhibit selectively the herpes
simplex virus type-1 UDG (19–21). Uracil-based ligands
able to inhibit the human UNG2 enzyme have also
been designed (22).
Recently, we reported the identiﬁcation of a novel
natural inhibitor of the B. subtilis UDG (23).
This inhibitor, named p56, is a small acidic protein
(56 amino acids) encoded by the B. subtilis lytic phage
f29. Unlike phage PBS2, the DNA genome of f29 does
not contain uracil residues. Protein p56 is synthesized
upon f29 infection and knocks out a host-encoded BER
system that could be harmful for viral replication if
uracil residues arise in the replicative intermediates (23).
In the present work, we have addressed some structural
features of protein p56 by sedimentation equilibrium,
sedimentation velocity and circular dichroism (CD)
spectroscopy. Moreover, using the E. coli UDG enzyme,
we performed a biochemical characterization of protein
p56 as an approach to understand its mechanism of
UDG inhibition. Our results revealed that protein p56
blocked the DNA-binding site of UDG. Thus, protein
p56 could mimic DNA structural features in order to
inhibit UDG.
MATERIALS AND METHODS
Purification of protein p56
Protein p56 was overproduced in E. coli BL21(DE3)
cells harbouring plasmid pCR2.1-TOPO.p56, and it was
puriﬁed following a large-scale puriﬁcation method
as previously described (23). Protein p56 concentration
was determined either by quantitative amino acid analysis
using a Pharmacia-Biochrom 20 Amino Acid Analyzer
or by UV absorbance spectroscopy. Amino terminal
sequencing of protein p56 was performed by Edman
degradation on a Perkin Elmer (Procise 494) Protein
Sequencer.
MALDI-TOFmass spectrometric analysis of protein p56
Matrix-assisted laser desorption/ionization time-of-ﬂight
(MALDI-TOF, Beckman, Palo Alto, CA, USA) mass
spectrometry of puriﬁed p56 protein was performed on
a Brucker Biﬂex Instrument (Bruker-Franzen Analytik,
Bremen, Germany) using insulin as standard. The spectra
(average of 100 shots) were recorded in the linear mode
at 19.5 kV.
Sedimentation equilibrium and sedimentation velocity
Sedimentation equilibrium experiments were performed
at 208C in an Optima XL-A (Beckman-Coulter) analytical
ultracentrifuge equipped with UV-visible optics, using
an An60Ti rotor with standard six-channel centrifuge
cells (12-mm optical path) and centrepieces of epon
charcoal. Protein p56 in buﬀer A (50mM Tris-HCl, pH
7.5, 50mMKCl) was centrifuged at 30 000 r.p.m. until
sedimentation equilibrium was reached. Then, absorbance
scans were taken at 280 nm. A range of protein
concentration from 25 to 500 mM was analysed. In all
cases, the baseline signals were measured after high-speed
centrifugation (42 000 r.p.m.). Whole-cell apparent weight
average molecular weights of p56 were determined using
the program EQASSOC (24). The partial speciﬁc volume
of p56 was 0.7331ml g1, calculated from the amino acid
composition with the program SEDNTERP (25).
Sedimentation velocity experiments were carried out
at 60 000 r.p.m. and 208C. Protein p56 (25–200 mM)
was equilibrated in buﬀer A. The sedimentation coeﬃcient
for p56 was calculated by direct linear least-squares
boundary modelling of the sedimentation velocity data
using the program SEDFIT (26). The sedimentation
coeﬃcients were corrected to standard conditions to get
the corresponding S20,w value using the SEDNTERP
program (25). The translational frictional coeﬃcient (f)
of p56 was determined from the molecular mass and
sedimentation coeﬃcient of the protein (27). The frictional
coeﬃcient of the equivalent hydrated sphere (f0) was
estimated using a hydration of 0.42 g H2O per g protein
(28). These values allowed us to calculate the translational
frictional ratio (f/f0), which in turn gives an estimation
of the shape of p56.
Circular dichroism assays
Before CD analysis, puriﬁed p56 was dialysed against
20mM NaH2PO4, pH 8.0 and diluted in the same buﬀer
to a protein concentration of 0.7mg/ml. CD spectra were
acquired in a J-720 spectropolarimeter ﬁtted with a peltier
temperature control accessory. Far-UV spectrum was
recorded in 0.1-mm optical path length quartz cells over
a wavelength range from 190 to 260 nm at a temperature
of 208C. The CD spectrum was the average of four
accumulations at a scanning speed of 20 nm/min and 1-nm
spectral bandwidth. The CD spectrum of the buﬀer alone
was subtracted from the experimental spectrum. To
obtain structural information, the CD data were analysed
using the following algorithms: CONTINLL (29) and
CDNN (30).
Temperature-associated changes in the p56 secondary
structure were measured by increasing the temperature
from 15 to 958C at two diﬀerent rates (15 and 458Ch1).
For temperature scans acquisition, puriﬁed p56
was dialysed against 20mM HEPES, pH 8.0 and diluted
in the same buﬀer to a protein concentration of 0.3mg/ml.
Changes in ellipticity at 218 nm were recorded in a
1-mm optical path length quartz cell. In addition, far-
UV CD spectra over a wavelength range from 210 to
260 nm were recorded at temperatures between 20 and
958C with temperature increments of 108C. The tempera-
ture was allowed to equilibrate for 1min before each
spectrum was acquired.
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UDG activity
Escherichia coli UDG preparations were purchased
from New England Biolabs. Then, they were dialysed
against buﬀer B (50mM Tris-HCl, pH 7.5, 50mM KCl,
1mM EDTA, 7mM b-mercaptoethanol, 5% glycerol) and
concentrated using a Microcon microconcentrator 10
(Amicon). To estimate the concentration of UDG,
aliquots from the protein preparation were analysed by
SDS-PAGE (15% polyacrylamide). Molecular weight
markers (Invitrogen) and increasing amounts of a
standard protein (f29 single-stranded DNA-binding
protein, 13.3 kDa) were run in the same gel. The gel
was stained with Coomassie Blue, and scanned by
densitometry. Under these conditions, a major band
with the mobility expected for UDG (25.7 kDa) was
detected. Since some minor bands were visualized, UDG
concentration was estimated by comparing the intensity of
the UDG bands with that of the standard protein.
To measure UDG activity, a 34-mer oligonucleotide
containing a single uracil residue at position 16 (ssDNA-
U16; from Isogen) was used as substrate. It was 50-labelled
with g-32PATP (3000Ci/mmol) (GE Healthcare) and T4
polynucleotide kinase (New England Biolabs). Reaction
mixtures (20 ml) contained increasing amounts of the
E. coli UDG preparation and the radiolabelled substrate
in buﬀer B. After incubation at 378C for 8min, samples
were treated with NaOH to a ﬁnal concentration of 0.2M,
and heated at 908C for 30min. Samples were then dried
in a Speed Vac, resuspended in 10 ml of formamide loading
buﬀer (95% formamide, 20mM EDTA, 0.05% xylene
cyanol, 0.05% bromophenol blue), and subjected to
electrophoresis in 8M urea/20% polyacrylamide gels.
The minimal UDG amount needed to obtain total
cleavage of the substrate was used to examine UDG
inhibition by p56.
Formation of UDG–p56 complexes
The theoretical isoelectric point of E. coli UDG and p56 is
6.67 and 4.17, respectively. To examine whether protein
p56 was able to interact with UDG, the indicated amounts
of both proteins were incubated in buﬀer B at room
temperature for 15min, kept at 48C for 15min, and
analysed by basic-native PAGE (16% polyacrylamide).
Tris-borate (TBE) buﬀer, pH 8.3, was used as running
buﬀer. Under these conditions, UDG–p56 complexes were
detected. Similar amounts of UDG–p56 complexes were
detected when UDG and p56 were incubated at 4, 28 or
378C for 30min.
DNA affinity chromatography
Denatured calf thymus DNA immobilized on cellulose
(GE Healthcare) was used. The DNA aﬃnity column
(150 ml; 1.1mg DNA/ml) was equilibrated with buﬀer C
(30mM Tris-HCl, pH 7.5, 1mM EDTA, 1mM dithio-
threitol). Then, UDG (300ml; 1.6mM) was applied to the
column under gravity ﬂow. After washing with 1.5ml of
buﬀer C, UDG bound to the column was eluted with
protein p56 (700 ml; 1.35mM). Elution fractions (100 ml
each) were dried in a Speed Vac, and resupended in
10 ml of loading buﬀer (40mM Tris-HCl, pH 6.8, 2% SDS,
15% glycerol). Proteins were resolved by SDS-Tricine-
PAGE (31). To analyse whether UDG–p56 complexes
were able to bind to the DNA aﬃnity column, a reaction
mixture (900 ml) containing 0.5mM of UDG and 1 mM
of protein p56 in buﬀer C was incubated at 48C for 30min.
Under these conditions, UDG–p56 complexes were
formed. The reaction mixture was subsequently loaded
onto the DNA aﬃnity column (150ml; 1.1 mg DNA/ml).
Column fractions (100ml each) were collected, dried in a
Speed Vac, resuspended in 10 ml of loading buﬀer, and
analysed by SDS-Tricine-PAGE.
Electrophoretic mobility shift assays
A f29 DNA region (121 bp) was ampliﬁed by the
polymerase chain reaction (PCR) using oligonucleotides
50-CGCATTGTATGAGCTTTCTAGG-30 and 50-ATTG
TTATATCGTATGAGTCAACAAAATC-30 as primers.
For this ampliﬁcation, Taq DNA polymerase (New
England Biolabs), a-32P-dATP (3000Ci/mmol) (GE
Healthcare) and dUTP instead of dTTP were used.
Reaction mixtures (20ml) contained 50mM Tris-HCl,
pH 7.5, 50mM KCl, 4% glycerol, radiolabelled DNA
(6.25 nM) and the indicated amounts of UDG and p56.
Samples were kept at 48C for 20min, mixed with glycerol
to a ﬁnal concentration of 8%, and then analysed by non-
denaturing PAGE (6% polyacrylamide). Gel electropho-
resis was performed at 48C. Gels were vacuum-dried and
autoradiographed.
RESULTS AND DISCUSSION
Protein p56 is a dimer in solution
Protein p56 from phage f29 was puriﬁed to near
homogeneity after expression in E. coli (23). MALDI-
TOF mass spectrometric analysis of puriﬁed p56 revealed
the existence of two forms. The major form had
6573.4Da, which agreed with the molecular weight of
the p56 monomer, as calculated from the DNA sequence
of the gene product (6565.3Da). The minor form
(6438Da) would correspond to p56 lacking the ﬁrst
Met residue, a fact that was conﬁrmed by determination
of the N-terminal amino acid sequence of the puriﬁed
protein. Furthermore, the amino acid analysis of p56 was
in agreement with the amino acid composition predicted
from the nucleotide sequence (data not shown). Protein
p56 has 12 aspartic or glutamic residues and 5 arginine or
lysine residues, which results in a low theoretical iso-
electric point (4.17). Its molar extinction coeﬃcient was
calculated to be 7450M1cm1 at 280 nm due to the
presence of 5 tyrosine residues.
Protein p56, which acts as an inhibitor of the B. subtilis
UDG, accumulates throughout the f29 lytic cycle.
At early stages of phage infection there are 104 copies
of p56 per infected cell, and it increases up to 105 at late
stages (23). Therefore, taking into account the cell volume
of infected cells (32), the intracellular concentration
of protein p56 would range from 15 to 150 mM throughout
the infective cycle. To determine the oligomerization state
of protein p56 in solution, sedimentation equilibrium
assays were performed at various p56 concentrations
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(25–500 mM), and all of them gave a similar sedimentation
pattern. At 75 mM, a physiological protein concentration,
the experimental data (Figure 1) are best ﬁt to an average
molecular mass (Mw,a) of 13 000 360, a value that
corresponds with the theoretical mass of a p56 dimer
(13 130Da). Similar average molecular masses were deter-
mined when p56 concentrations of 25 mM (12 850 250),
200mM (13 370 400) and 500mM (13 110 390) were
used. Hence, p56 is a dimeric protein at physiological
concentrations.
Sedimentation velocity proﬁles of native protein p56
(Figure 1) ﬁtted well to a single sedimenting species, with a
S20,w value of 1.6 0.05S and a Mw,a of 13 500 that
corresponds with that obtained from the sedimentation
equilibrium and from the theoretical mass of a p56 dimer.
No improvement in the best-ﬁt parameters was obtained
if more sedimenting species were considered, an indication
of sample homogeneity. The frictional ratio (f/f0)
calculated from the values obtained in the analytical
ultracentrifugation was 1.22 0.05. Therefore, the hydro-
dynamic behaviour of the p56 dimer deviates from the one
corresponding to a rigid spherical particle, which has an f/
f0 value=1.0. We conclude that the p56 dimer may have
an ellipsoidal shape.
Protein p56 has a high content of b-strands
To obtain experimental information on the relative
amounts of the secondary structural elements of protein
p56, far-UV CD spectroscopic analyses were performed.
The CD spectrum of p56 in the far-UV region
was characterized by two minima around 195 and
215 nm and a maximum at 200 nm, indicative of a protein
with low content in a-helices (Figure 2). The overall
secondary structure of p56 was estimated by two
deconvolution methods of CD spectra (see Materials
and Methods section). The results gave a consensus
average of 4.6% a-helices, 39% b-strands and 55.3%
assigned to turns and non-regular structures. Both
methods gave similar estimations of the content of
b-strands and random elements.
Temperature-induced changes in the secondary struc-
ture of protein p56 were analysed by CD spectroscopy
(Figure 3). Speciﬁcally, we monitored the changes in the
ellipticity at 218 nm by increasing the temperature from
15 to 958C. The results showed that the CD of p56
changed as a function of the temperature (Figure 3A).
The temperature CD transition curve of p56 at 218 nm was
characterized by a decrease in the ellipticity between
30 and 408C. Additional changes in the curve region
Figure 1. Analytical ultracentrifugation proﬁle of protein p56. Sedimentation equilibrium proﬁle of 75 mM p56 taken at 30 000 r.p.m., 208C and at a
wavelength of 280 nm. Grey circles represent the experimental data; the continuous line is the best ﬁt Mw (13 000 360); the discontinuous line is the
theoretical gradient of a p56 monomer. The residuals to the ﬁt are shown in the upper part of the ﬁgure. Insert: Sedimentation velocity
(60 000 r.p.m., 208C) distributions of the same p56 preparation showed in the main ﬁgure.
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between 40 and 958C were not observed, and p56 protein
remained soluble up to 958C. Comparison of the spectra
acquired at 20 and 608C (Figure 3B) showed loss of
secondary structure of p56 after the temperature-induced
change. This structural change was reversible in vitro and
independent of the temperature scanning rate (15 or
608Ch1; data not shown).
From these set of results we conclude that protein p56
has a low a-helical content, but a high percentage of
b-strands. Folding of the protein appears to be a single
reversible process, indicative of a high structural stability.
Protein p56 inhibits theE. coliUDG
Our previous work showed that addition of puriﬁed
protein p56 to B. subtilis cell extracts inhibited the
endogenous UDG activity (23). The deduced sequence
of the B. subtilis UDG enzyme shares homology to the
E. coli UDG (33), which belongs to a family of highly
conserved UDGs (Family-1). The activity of UDG is to
remove uracil from both ssDNAs and dsDNAs, regardless
of the partner base U:A or U:G (7). These enzymes
hydrolyse the N-glycosidic bond between the uracil
residue and the deoxyribose sugar of the DNA backbone,
generating an apurinic-apyrimidinic (AP) site. The AP site
is further recognized by an AP endonuclease, which
cleaves the phophodiester bond of the DNA backbone 50
to the AP site (34). In the absence of an AP endonuclease
activity, chemical cleavage of the DNA at the AP site can
be achieved by treatment with heat and alkali.
To examine whether protein p56 was able to inhibit the
E. coli UDG activity, E. coli UDG (5 nM) and p56 (from
0.04 to 2 mM) were incubated at room temperature for
15min, and kept at 48C for 15min (formation of UDG–
p56 complexes). Then, a 34-mer single-stranded oligonu-
cleotide containing a single uracil residue at position 16
(ssDNA-U16) was added to the reaction mixture. After
8min at 378C, the reactions were treated with NaOH.
As shown in Figure 4, total cleavage of the substrate was
detected in the absence of protein p56, whereas nearly 20,
65 and 85% of the substrate remained intact when 0.16,
0.8 and 2 mM of p56, respectively, were used. Inhibition of
the E. coli UDG by protein p56 was also observed when a
34-bp dsDNA carrying a U:G mismatch at position 16
was used as substrate (data not shown). Therefore,
we conclude that protein p56 functions as an inhibitor
of the E. coli UDG enzyme.
Figure 2. CD spectrum of native p56 in the far-UV region at 208C.
Protein p56 (0.7mg/ml) was in 20mM NaH2PO4, pH 8.0. Experimental
data were acquired using 0.1-mm optical path length quartz cells.
Figure 3. Temperature-associated changes in the secondary structure of
p56. (A) Temperature CD transition curve of p56 in 20mM HEPES,
pH 8.0, measured at 218 nm, between 15 and 608C. The continuous line
represents the best ﬁt of a two state model to the experimental data.
(B) CD spectra of p56 in the far-UV region at the indicated
temperatures. 1-mm optical path length quartz cells were used.
Figure 4. Protein p56 inhibits E. coli UDG activity. The 50-end
32P-labelled ssDNA-U16 substrate (S) (1.3 nM) was incubated with
UDG (5 nM) in the absence or presence of p56. After 8min, the
reaction mixtures were treated with NaOH. Formation of the cleavage
product (P) was monitored by autoradiography after resolution on
8M urea/20% polyacrylamide gels.
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The E. coliUDG–p56 complex is stable
at high urea concentrations
Protein p56 targets the E. coli UDG enzyme in vitro,
forming a complex (UDG–p56) that migrated slightly
faster than free UDG in a non-denaturing polyacrylamide
gel (23) (Figure 5). To analyse the stability of the UDG–
p56 complex at high urea concentrations, preformed
UDG–p56 complexes were incubated with diﬀerent
concentrations of urea (up to 8M) for 30min, and then
analysed by non-denaturing PAGE (Figure 5). In this
assay, preformed UDG–Ugi complexes were used as
control. Like protein p56, Ugi from the B. subtilis phage
PBS2 inactivates the E. coli UDG (15). As expected,
the UDG–Ugi complexes were not aﬀected by incubation
with 8M urea (35,36). The amount of UDG–p56
complexes in the absence of urea (data not shown) was
similar to that detected at 4M urea (Figure 5). UDG–p56
complexes remained intact up to 6M urea, indicating that
protein p56 forms a tight complex with the E. coli UDG
enzyme. Moreover, free protein p56 was not denatured
with 8M urea, indicating that p56 is unusually stable
at high urea concentrations.
Protein p56 blocks binding of E. coliUDG to DNA
To understand the mechanism underlying UDG inhibition
by protein p56, we investigated whether protein p56 was
able to dissociate preformed UDG–DNA complexes.
To this end, aﬃnity chromatography experiments using
denatured calf thymus DNA immobilized on cellulose
were performed. As shown in Figure 6A, E. coli UDG was
able to bind to the DNA aﬃnity column. After the
washing steps, protein p56 was applied to the column and
the elution fractions (from E1 to E7) were analysed by
SDS-Tricine-PAGE. The UDG enzyme eluted with
protein p56, indicating that p56 was able to compete
with DNA for binding to UDG. Subsequently, we studied
whether protein p56 impaired binding of E. coli UDG to
DNA. In this assay, UDG–p56 complexes were ﬁrst
formed and then they were loaded onto the DNA aﬃnity
column. Again, the column fractions were analysed by
SDS-Tricine-PAGE (Figure 6B). Both proteins UDG and
p56 co-eluted, indicating that p56 blocked DNA binding
by UDG. This result was further conﬁrmed by electro-
phoretic mobility shift assays (Figure 7). In this case,
a dsDNA fragment (121 bp) containing uracil instead of
thymine residues (60% A:U) was incubated with either
UDG alone or preformed UDG–p56 complexes. A single
band moving slower than free DNA was visualized when
the DNA substrate was incubated with free UDG, but not
in the samples containing UDG–p56 complexes.
In conjunction, these results demonstrate that protein
p56 prevents the UDG enzyme from binding to DNA.
Figure 5. Eﬀect of urea on the stability of preformed UDG–p56
complexes. UDG (1.9 mM) was incubated with either p56 (6.4 mM) or
Ugi (4.2 mM; New England Biolabs) at room temperature for 15min,
and kept at 48C for 15min to allow formation of UDG–p56 and
UDG–Ugi complexes. Then, the reactions were incubated with the
indicated amount of urea for 30min at room temperature, and analysed
by basic-native PAGE (16% polyacrylamide). Gel electrophoresis was
performed at 48C. The gel was stained with SyproRuby (Molecular
Probes).
Figure 6. Protein p56 prevents UDG from binding to DNA. (A) UDG
was applied to a ssDNA aﬃnity column. The enzyme was neither
detected in the ﬂow-through (FT) nor in the washing steps (W). Protein
p56 was used to elute UDG bound to the column. The elution fractions
(E1 to E7) were separated by SDS-Tricine-PAGE. (B) Preformed
UDG–p56 complexes were loaded onto a DNA aﬃnity column.
Puriﬁed UDG (1.8 mg) and protein p56 (2mg) were run in the same
gel (lane C). The amount of both UDG (white circle) and p56 (black
circle) in each fraction was determined by densitometric scanning of the
gel stained with Coomassie Blue.
Figure 7. Protein p56 inhibits DNA-binding ability of UDG.
Electrophoretic mobility shift assays were performed in the absence
or in the presence of the indicated proteins. A radiolabelled dsDNA
fragment (121 bp) containing uracil in place of thymine residues was
used as substrate.
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Ugi replaces protein p56 previously bound to E. coliUDG
Ugi functions by mimicking the structure of DNA.
Speciﬁcally, it mimics phosphate groups and UDG–
DNA interactions (hydrogen bonds and hydrophobic
contacts) (16–18). Unlike p56, Ugi (84 residues) is a
monomer in solution (35). An alignment of the primary
structures of protein p56 and Ugi is shown in Figure 8. The
regions of p56 spanning from Val12 to Gln23 (region A)
and from Leu31 to Leu50 (region B) showed homology to
the regions of Ugi spanning from Leu4 to Gln15 and from
Leu23 to Val43, respectively. According to the X-ray
crystal structure of Ugi in complex with E. coli UDG (18),
several amino acids of the Ugi region spanning residues
Leu23 and Val43 contact with UDG.
As shown above, protein p56 interacts with E. coli
UDG and impairs its DNA-binding activity. This eﬀect
could be due to an indirect conformational change in the
DNA-binding site of UDG. Alternatively, p56 could
directly interact with the DNA-binding domain of
UDG leading to its physical occlusion. To discriminate
between both possibilities, we investigated whether Ugi
was able to replace protein p56 already bound to UDG.
Thus, preformed UDG–p56 complexes were incubated
with Ugi for 10min at room temperature, and then
analysed by non-denaturing PAGE. As shown in Figure 9,
UDG–Ugi but not UDG–p56 complexes were detected,
indicating that Ugi was able to replace protein p56.
Therefore, protein p56 appears to block the DNA-binding
site of UDG rather than to induce an indirect conforma-
tional change of the enzyme.
CONCLUSIONS
Proteins can mimic DNA structures as a mechanism to
block DNA-binding enzymes. At present, only a small
number of DNA mimic proteins have been discovered.
Although this class of proteins are structurally diverse,
they tend to resemble some DNA structural features,
such as the phosphate backbone of DNA or the hydrogen-
bonding properties of the nucleotide bases (37,38).
The Ocr protein from the E. coli phage T7 is an example
of DNA mimicry. It binds tightly to type I DNA
restriction and modiﬁcation enzymes (39). Biophysical
and crystallographic studies revealed that the Ocr dimer
mimics 24 bp of B-form DNA containing a central bend
(40,41). Moreover, Ugi encoded by the B. subtilis phage
PBS2 acts as a UDG inhibitor by mimicking electro-
negative and structural features of duplex DNA (16–18).
A most recent example of DNA mimicry is Mfpa,
a Mycobacterium tuberculosis protein that binds to DNA
gyrase. MfpA exhibits a highly unusual right-handed beta-
helix fold (42).
B. subtilis UDG is the in vivo target of p56, an early and
small protein (56 amino acids) encoded by phage f29.
Inhibition of the host UDG by protein p56 is likely related
to the mechanism of f29 DNA replication (23). We show
in this study that protein p56 has a high content of
b-strands (around 40%), and forms dimers in solution at
physiological concentrations. In addition, we demonstrate
that protein p56 inhibits the E. coli UDG enzyme in vitro.
Several features of protein p56 suggest that it could be
a novel naturally occurring DNA mimicry. First, protein
p56 competes with DNA for binding to UDG. Second, the
interaction between p56 and UDG blocks the interaction
between UDG and DNA. Third, the Ugi protein, which
interacts with the DNA-binding groove of UDG, is
able to replace protein p56 previously bound to the
UDG enzyme. Fourth, like Ocr and Ugi, p56 is a highly
acidic protein. In most of the known DNA mimic
proteins, carboxylates from the side-chains of aspartates
and glutamates generate an overall charge distribution
that resembles the DNA phosphate backbone (37).
Further resolution of the 3D structure of both protein
p56 and the UDG–p56 complex will reveal whether
protein p56 functions as a structural mimic of the DNA
substrate recognized by UDG.
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